CN111790007B - 一种温敏型鹿茸软骨基质水凝胶材料的制备方法及应用 - Google Patents
一种温敏型鹿茸软骨基质水凝胶材料的制备方法及应用 Download PDFInfo
- Publication number
- CN111790007B CN111790007B CN202010550889.6A CN202010550889A CN111790007B CN 111790007 B CN111790007 B CN 111790007B CN 202010550889 A CN202010550889 A CN 202010550889A CN 111790007 B CN111790007 B CN 111790007B
- Authority
- CN
- China
- Prior art keywords
- buffer solution
- pilose antler
- mixing
- liquid ratio
- cartilage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000003056 antler Anatomy 0.000 title claims abstract description 54
- 239000000017 hydrogel Substances 0.000 title claims abstract description 32
- 239000000463 material Substances 0.000 title claims abstract description 30
- 102000055008 Matrilin Proteins Human genes 0.000 title claims abstract description 22
- 108010072582 Matrilin Proteins Proteins 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000011159 matrix material Substances 0.000 claims abstract description 48
- 239000007788 liquid Substances 0.000 claims abstract description 35
- 239000007853 buffer solution Substances 0.000 claims abstract description 26
- 238000002156 mixing Methods 0.000 claims abstract description 26
- 108010039627 Aprotinin Proteins 0.000 claims abstract description 24
- 229960004405 aprotinin Drugs 0.000 claims abstract description 24
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims abstract description 24
- 230000001079 digestive effect Effects 0.000 claims abstract description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 13
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 102000004142 Trypsin Human genes 0.000 claims abstract description 12
- 108090000631 Trypsin Proteins 0.000 claims abstract description 12
- 239000012588 trypsin Substances 0.000 claims abstract description 12
- 102000057297 Pepsin A Human genes 0.000 claims abstract description 11
- 108090000284 Pepsin A Proteins 0.000 claims abstract description 11
- 229940111202 pepsin Drugs 0.000 claims abstract description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000009777 vacuum freeze-drying Methods 0.000 claims abstract description 7
- 239000003599 detergent Substances 0.000 claims abstract description 6
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 6
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 6
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 6
- 239000002516 radical scavenger Substances 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 5
- 238000000227 grinding Methods 0.000 claims abstract description 5
- 238000011534 incubation Methods 0.000 claims abstract description 5
- 239000008280 blood Substances 0.000 claims abstract description 4
- 210000004369 blood Anatomy 0.000 claims abstract description 4
- 238000007710 freezing Methods 0.000 claims abstract description 4
- 230000008014 freezing Effects 0.000 claims abstract description 4
- 239000002184 metal Substances 0.000 claims abstract description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 4
- 238000002791 soaking Methods 0.000 claims abstract description 4
- 239000006228 supernatant Substances 0.000 claims description 46
- 239000000843 powder Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 10
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000002639 bone cement Substances 0.000 claims description 6
- 230000029087 digestion Effects 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 5
- 229920002113 octoxynol Polymers 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 4
- 230000010355 oscillation Effects 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 239000003899 bactericide agent Substances 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 abstract description 36
- 210000001519 tissue Anatomy 0.000 abstract description 25
- 210000004027 cell Anatomy 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 17
- 238000000034 method Methods 0.000 abstract description 7
- 230000002792 vascular Effects 0.000 abstract description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract description 3
- 210000002744 extracellular matrix Anatomy 0.000 abstract description 3
- 210000003321 cartilage cell Anatomy 0.000 abstract description 2
- 230000000717 retained effect Effects 0.000 abstract description 2
- 229960001484 edetic acid Drugs 0.000 abstract 2
- 239000008055 phosphate buffer solution Substances 0.000 abstract 2
- 238000010257 thawing Methods 0.000 abstract 1
- 230000007547 defect Effects 0.000 description 18
- 210000000988 bone and bone Anatomy 0.000 description 11
- 210000001188 articular cartilage Anatomy 0.000 description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 206010052428 Wound Diseases 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 206010007710 Cartilage injury Diseases 0.000 description 5
- 206010020649 Hyperkeratosis Diseases 0.000 description 5
- 230000033115 angiogenesis Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 108010025020 Nerve Growth Factor Proteins 0.000 description 3
- 102000015336 Nerve Growth Factor Human genes 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000263 cytotoxicity test Toxicity 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 238000013508 migration Methods 0.000 description 3
- 230000005012 migration Effects 0.000 description 3
- 229940053128 nerve growth factor Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 206010061762 Chondropathy Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 238000002784 cytotoxicity assay Methods 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000001878 scanning electron micrograph Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 210000005065 subchondral bone plate Anatomy 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000014429 Insulin-like growth factor Human genes 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 102100034998 Thymosin beta-10 Human genes 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940116978 human epidermal growth factor Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 108010044465 thymosin beta(10) Proteins 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000009790 vascular invasion Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3608—Bone, e.g. demineralised bone matrix [DBM], bone powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
- A61L27/3654—Cartilage, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010550889.6A CN111790007B (zh) | 2020-06-16 | 2020-06-16 | 一种温敏型鹿茸软骨基质水凝胶材料的制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010550889.6A CN111790007B (zh) | 2020-06-16 | 2020-06-16 | 一种温敏型鹿茸软骨基质水凝胶材料的制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111790007A CN111790007A (zh) | 2020-10-20 |
CN111790007B true CN111790007B (zh) | 2022-04-05 |
Family
ID=72803364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010550889.6A Active CN111790007B (zh) | 2020-06-16 | 2020-06-16 | 一种温敏型鹿茸软骨基质水凝胶材料的制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111790007B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113876693A (zh) * | 2021-10-25 | 2022-01-04 | 鸳鸯故里(屏南)生态农业科技有限公司 | 一种促创面愈合的鹿茸多肽单体凝胶制剂及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR200352255Y1 (ko) * | 1999-05-21 | 2004-06-05 | 주식회사 하이닉스반도체 | 디디알 메모리의 입력 버퍼 |
CN104971380B (zh) * | 2014-04-11 | 2017-12-15 | 山东隽秀生物科技股份有限公司 | 一种脱细胞基质修复凝胶及其制备新方法 |
CN107137777A (zh) * | 2017-05-31 | 2017-09-08 | 合肥创沃科技有限公司 | 一种鹿茸胶原蛋白复合生物玻璃修复材料的制备方法 |
KR102250064B1 (ko) * | 2018-11-12 | 2021-05-07 | 아주대학교산학협력단 | 생분해 기간 및 물성 조절 가능한 동물 연골 유래 조직 하이드로젤의 제조 방법 |
CN109621010A (zh) * | 2018-12-17 | 2019-04-16 | 浙江华臻医疗器械有限公司 | 一种脱细胞软骨基质及其制备方法 |
-
2020
- 2020-06-16 CN CN202010550889.6A patent/CN111790007B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111790007A (zh) | 2020-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2307065B1 (en) | Compositions and methods for tissue filling and regeneration | |
EP2182887B1 (en) | A method for improvement of differentiation of mesenchymal stem cells using a double-structured tissue implant | |
CN106456837A (zh) | 最终消毒的来自细胞外基质的水凝胶的制备方法 | |
CN110975010B (zh) | 一种胎盘组织基质材料及其制备方法 | |
CN111905146B (zh) | 一种保留天然羟基磷灰石的脱细胞骨基质水凝胶及其制备方法 | |
CN110152067B (zh) | 组织工程骨支架及其制备方法 | |
WO2010081408A1 (zh) | 一种生物活性组织再生膜及其制备方法 | |
JPH10509080A (ja) | 細胞間マトリックス微粒子を備えた生重合体フォーム | |
CN108670946A (zh) | 治疗关节软骨损伤的细胞凝胶制剂及其用途和所用的保持冻存细胞活性的凝胶溶液 | |
CN107789668A (zh) | 具有多层结构的仿生胶原蛋白骨修复材料及其制备方法 | |
CN108236739B (zh) | 一种应用于软骨损伤修复的复合材料 | |
CN111790007B (zh) | 一种温敏型鹿茸软骨基质水凝胶材料的制备方法及应用 | |
CN112076350B (zh) | 具有纳米-微米复合结构和高矿物质密度的仿生矿化水凝胶及其制备方法与及应用 | |
CN101690830A (zh) | 组织工程用仿生软骨细胞外基质的制备方法 | |
CN112773932A (zh) | 一种具有定向孔结构的促血管化组织修复材料及其制备方法和应用 | |
CN112755248A (zh) | 基于卵巢或阴道脱细胞基质的3d打印复合生物墨水的制备方法及应用 | |
CN112370571A (zh) | 治疗颌面部骨缺损的骨组织工程支架材料及其合成方法 | |
CN112691235A (zh) | 以物理方法为主制备人和猪脂肪源性脱细胞基质制备及应用 | |
CN115845138A (zh) | 一种促进血管再生的高成骨活性骨修复材料制备方法和应用 | |
Li et al. | 3D printed hydroxyapatite/silk fibroin/polycaprolactone artificial bone scaffold and bone tissue engineering materials constructed with double-transfected bone morphogenetic protein-2 and vascular endothelial growth factor mesenchymal stem cells to repair rabbit radial bone defects | |
CN114931670B (zh) | 活性物质及其自愈合水凝胶在修复软骨中的应用 | |
CN118022064B (zh) | 一种NPP/C-HA/rhBMP-2复合支架及其制备方法和应用 | |
CN115006604A (zh) | 可通过仿生再矿化促进骨再生的dSIS海绵状支架、其制备方法及所得产品 | |
Hamza et al. | FABRICATION AND CHARACTERIZATION OF LYOPHILIZED ACELLULAR BOVINE ARTICULAR CARTILAGE MATRIX FOR TISSUE-ENGINEERING APPLICATIONS. | |
CN116440329A (zh) | 用于修复软骨的脱细胞软骨基质支架和凋亡小体组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20201020 Assignee: ZHEJIANG DOUDOUBAO TRADITIONAL CHINESE MEDICINE RESEARCH Co.,Ltd. Assignor: TAIZHOU University Contract record no.: X2023980033952 Denomination of invention: Preparation and application of a temperature sensitive pilose antler cartilage matrix hydrogel material Granted publication date: 20220405 License type: Common License Record date: 20230325 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20201020 Assignee: Xianju County Yangming Agricultural Development Co.,Ltd. Assignor: TAIZHOU University Contract record no.: X2024330000539 Denomination of invention: Preparation and application of a temperature sensitive pilose antler cartilage matrix hydrogel material Granted publication date: 20220405 License type: Common License Record date: 20240905 Application publication date: 20201020 Assignee: Taizhou Liwei Agricultural Machinery Co.,Ltd. Assignor: TAIZHOU University Contract record no.: X2024330000538 Denomination of invention: Preparation and application of a temperature sensitive pilose antler cartilage matrix hydrogel material Granted publication date: 20220405 License type: Common License Record date: 20240905 Application publication date: 20201020 Assignee: Taizhou Xingchen Agricultural Machinery Co.,Ltd. Assignor: TAIZHOU University Contract record no.: X2024330000537 Denomination of invention: Preparation and application of a temperature sensitive pilose antler cartilage matrix hydrogel material Granted publication date: 20220405 License type: Common License Record date: 20240905 Application publication date: 20201020 Assignee: Taizhou Baoquan Agricultural Machinery Co.,Ltd. Assignor: TAIZHOU University Contract record no.: X2024330000536 Denomination of invention: Preparation and application of a temperature sensitive pilose antler cartilage matrix hydrogel material Granted publication date: 20220405 License type: Common License Record date: 20240905 Application publication date: 20201020 Assignee: Zhejiang Wujian Agricultural Technology Co.,Ltd. Assignor: TAIZHOU University Contract record no.: X2024330000535 Denomination of invention: Preparation and application of a temperature sensitive pilose antler cartilage matrix hydrogel material Granted publication date: 20220405 License type: Common License Record date: 20240905 |